Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5

被引:142
作者
Diaz-Griffero, Felipe
Li, Xing
Javanbakht, Hassan
Song, Byeongwoon
Welikala, Sohanya
Stremlau, Matthew
Sodroski, Joseph
机构
[1] Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Dana Farber Canc Inst,Dept Pathol,Div AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA
关键词
human immunodeficiency virus; restriction factor; TRIM5; TRIMCyp; aggresome; proteasome; ubiquitin; cytoplasmic body; tripartite motif; RBCC;
D O I
10.1016/j.virol.2005.12.040
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
TRIM5 alpha and TRIMCyp are retroviral restriction factors that, like other members of the tripartite motif (TRIM) family, contain RING, B-box 2 and coiled-coil domains. We found that both proteins are rapidly turned over, with half-lives of 50-60 min. Polyubiquitylation and rapid degradation of TRIM5a depended upon intact RING and B-box 2 domains. A chimera consisting of monkey TRIM5 alpha with a RING domain of human TRIM21 exhibited a half-life of 210 min, yet potently restricted human immunodeficiency virus; therefore, rapid turnover of TRIM5 alpha is not required for its antiretroviral activity. TRIM5 alpha forms cytoplasmic bodies that contain other polyubiquitylated proteins, heat shock proteins and dynein, and thus resemble aggresome precursors. Consistent with this interpretation, proteasomal inhibitors triggered the formation of TRIM5 alpha(rh)-containing aggresomes in a micro tubule-dependent manner. Thus, TRIM5 alpha levels in the cell are maintained by continuous synthesis and rapid proteasome-mediated degradation, imbalances in which result in the formation of pre-aggresomal cytoplasmic bodies. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:300 / 315
页数:16
相关论文
共 53 条
[41]   Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1 [J].
Sayah, DM ;
Sokolskaja, E ;
Berthoux, L ;
Luban, J .
NATURE, 2004, 430 (6999) :569-573
[42]   TRIM5a selectively binds a restriction-sensitive retroviral capsid [J].
Sebastian, S ;
Luban, J .
RETROVIROLOGY, 2005, 2 (1)
[43]   TRIM5α association with cytoplasmic bodies is not required for antiretroviral activity [J].
Song, B ;
Diaz-Griffero, F ;
Park, DH ;
Rogers, T ;
Stremlau, M ;
Sodroski, J .
VIROLOGY, 2005, 343 (02) :201-211
[44]   Retrovirus restriction by TRIM5α variants from old world and new world primates [J].
Song, B ;
Javanbakht, H ;
Perron, M ;
Park, DH ;
Stremlau, M ;
Sodroski, J .
JOURNAL OF VIROLOGY, 2005, 79 (07) :3930-3937
[45]   Species-specific variation in the B30.2(SPRY) domain of TRIM5α determines the potency of human immunodeficiency virus restriction [J].
Stremlau, M ;
Perron, M ;
Welikala, S ;
Sodroski, J .
JOURNAL OF VIROLOGY, 2005, 79 (05) :3139-3145
[46]   The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys [J].
Stremlau, M ;
Owens, CM ;
Perron, MJ ;
Kiessling, M ;
Autissier, P ;
Sodroski, J .
NATURE, 2004, 427 (6977) :848-853
[47]  
STREMLAU M, IN PRESS P NATL ACAD
[48]   Two B or not two B? Overview of the rapidly expanding B-box family of proteins [J].
Torok, M ;
Etkin, LD .
DIFFERENTIATION, 2001, 67 (03) :63-71
[49]   α-synuclein is degraded by both autophagy and the proteasome [J].
Webb, JL ;
Ravikumar, B ;
Atkins, J ;
Skepper, JN ;
Rubinsztein, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (27) :25009-25013
[50]  
Wigley WC, 1999, J CELL BIOL, V145, P481